Karmelsonix Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Karmelsonix Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Karmelsonix Limited Formerly known as Salus Technologies Limited. The Group's principal activities are researching, developing and commercialising medical devices. Its products primarily include non-invasive clinical solutions for patients with cardio-pulmonary disorders such as asthma, congestive heart failure (CHF), acute respiratory distress syndrome (ARDS), obstructive sleep apnea (OSA), emphysema, and chronic obstructive pulmonary disease (COPD). The Group acquired PulmoSonix Ltd and Karmel Sonix (Israel) Ltd in 21 November 2006 and disposed of its interest in Advanced Wound Care Pty Ltd in 14 December 2006. It operates in Australia and Israel.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report